SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-22-004359
Filing Date
2022-01-31
Accepted
2022-01-31 08:01:03
Documents
137
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f20f2021_universe.htm   iXBRL 20-F 2268764
2 DESCRIPTION OF SECURITIES f20f2021ex2-3_universephar.htm EX-2.3 92316
3 ENGLISH TRANSLATION OF THE WORKING CAPITAL LOAN CONTRACT ENTERED INTO BY AND BET f20f2021ex4-12_universephar.htm EX-4.12 113432
4 ENGLISH TRANSLATION OF THE REAL ESTATE PROPERTY PURCHASE AGREEMENT ENTERED INTO f20f2021ex4-13_universephar.htm EX-4.13 22262
5 ENGLISH TRANSLATION OF THE WORKING CAPITAL LOAN CONTRACT ENTERED INTO BY AND BET f20f2021ex4-14_universephar.htm EX-4.14 124459
6 ENGLISH TRANSLATION OF THE CONSTRUCTION AGREEMENT ENTERED INTO BY AND BETWEEN JI f20f2021ex4-15_universephar.htm EX-4.15 162891
7 ENGLISH TRANSLATION OF THE WORKING CAPITAL LOAN CONTRACT ENTERED INTO BY AND BET f20f2021ex4-16_universephar.htm EX-4.16 134179
8 ENGLISH TRANSLATION OF THE ADVERTISING SERVICE AGREEMENT ENTERED INTO BY AND BET f20f2021ex4-17_universephar.htm EX-4.17 65992
9 LIST OF SUBSIDIARIES OF THE REGISTRANT f20f2021ex8-1_universephar.htm EX-8.1 3303
10 CERTIFICATION f20f2021ex12-1_universephar.htm EX-12.1 11048
11 CERTIFICATION f20f2021ex12-2_universephar.htm EX-12.2 10988
12 CERTIFICATION f20f2021ex13-1_universephar.htm EX-13.1 5773
13 CERTIFICATION f20f2021ex13-2_universephar.htm EX-13.2 5737
14 CONSENT OF ALLBRIGHT LAW OFFICES f20f2021ex15-1_universephar.htm EX-15.1 5538
20 GRAPHIC img_001.jpg GRAPHIC 73004
21 GRAPHIC img_002.jpg GRAPHIC 71764
22 GRAPHIC fin_001.jpg GRAPHIC 16886
23 GRAPHIC fin_002.jpg GRAPHIC 7423
24 GRAPHIC ex4-12_001.jpg GRAPHIC 971
25 GRAPHIC ex4-12_002.jpg GRAPHIC 1424
26 GRAPHIC ex4-12_003.jpg GRAPHIC 1462
27 GRAPHIC ex4-12_004.jpg GRAPHIC 1449
28 GRAPHIC ex4-12_005.jpg GRAPHIC 1475
29 GRAPHIC ex4-12_006.jpg GRAPHIC 1446
30 GRAPHIC ex4-12_007.jpg GRAPHIC 1441
31 GRAPHIC ex4-12_008.jpg GRAPHIC 1430
32 GRAPHIC ex4-12_009.jpg GRAPHIC 35653
33 GRAPHIC ex4-13_001.jpg GRAPHIC 4565
34 GRAPHIC ex4-13_002.jpg GRAPHIC 7209
35 GRAPHIC ex4-14_001.jpg GRAPHIC 971
36 GRAPHIC ex4-14_002.jpg GRAPHIC 118998
37 GRAPHIC ex4-16_001.jpg GRAPHIC 40301
38 GRAPHIC ex4-17_001.jpg GRAPHIC 3694
39 GRAPHIC ex4-17_002.jpg GRAPHIC 3570
40 GRAPHIC ex15-1_001.jpg GRAPHIC 8239
41 GRAPHIC ex15-1_002.jpg GRAPHIC 2872
  Complete submission text file 0001213900-22-004359.txt   9857342

Data Files

Seq Description Document Type Size
15 XBRL SCHEMA FILE upc-20210930.xsd EX-101.SCH 90856
16 XBRL CALCULATION FILE upc-20210930_cal.xml EX-101.CAL 46805
17 XBRL DEFINITION FILE upc-20210930_def.xml EX-101.DEF 348421
18 XBRL LABEL FILE upc-20210930_lab.xml EX-101.LAB 609706
19 XBRL PRESENTATION FILE upc-20210930_pre.xml EX-101.PRE 359930
131 EXTRACTED XBRL INSTANCE DOCUMENT f20f2021_universe_htm.xml XML 866707
Mailing Address 265 JINGJIU AVENUE JINGGANGSHAN ECON. AND TECH. DEV. ZONE JI'AN, JIANGXI F4 343100
Business Address 265 JINGJIU AVENUE JINGGANGSHAN ECON. AND TECH. DEV. ZONE JI'AN, JIANGXI F4 343100 86-0796-8403309
Universe Pharmaceuticals INC (Filer) CIK: 0001809616 (see all company filings)

IRS No.: 000000000 | State of Incorp.: F4 | Fiscal Year End: 0930
Type: 20-F | Act: 34 | File No.: 001-40231 | Film No.: 22571379
SIC: 2834 Pharmaceutical Preparations